Rani Therapeutics Holdings, Inc. - Class A (RANI) analyst actions
Rating and price-target actions on RANI in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the RANI overview →
1 measured RANI analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill® for the Treatment of Obesity in Collaboration with ProGen | Press release | -1.42% | -0.71% |
Keep exploring
More RANI: earnings → · SEC filings → · RANI overview →